Critical Partnerships: How to Develop a Trans-Disciplinary Research Team

Author:

Waite Kristin A.1ORCID,Pronovost Peter J.23,Barnholtz-Sloan Jill S.14ORCID

Affiliation:

1. Trans Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA

2. University Hospitals Health System, Shaker Heights, OH 44106, USA

3. UH Quality Care Organization and UH Accountable Care Organization, University Hospitals Health System, Shaker Heights, OH 44106, USA

4. Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, MD 20892, USA

Abstract

Trans-disciplinary science will continue to be critical for the next wave of scientific advancement to fully understand cancer development, progression, and treatment. The shift from the independent investigator to either leading or being a productive member of a scientific team can be successful by focusing on some key elements that can build and strengthen interactions with a diverse group of people. These include the selection of the team, communication, leadership and mentorship, shared goals, responsibility to the team, authorship, and proactively dealing with conflict. While there are extensive books written on developing teams in the business world, and larger pieces in the medical arena, we attempt to provide here a concise, high-level view as a starting point for those that may be moving from being an independent researcher and are developing their own, larger, trans-disciplinary teams.

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference36 articles.

1. Stokes, D. (1997). Pasteur’s Quadrant—Basic Science and Technological Innovation, Brookings Institution Press.

2. (2023, August 01). Available online: https://www.aacr.org/professionals/research/scientific-achievement-awards-and-lectureships/scientific-award-recipients/aacr-team-science-award-recipients/.

3. GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity;Heitzeneder;Cancer Cell,2022

4. Immune-Based Approaches for the Treatment of Pediatric Malignancies;Bosse;Annu. Rev. Cancer Biol.,2020

5. The NIH-led research response to COVID-19;Collins;Science,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3